#Astrazeneca

Presented by AstraZeneca {beacon} Healthcare Healthcare The Big Story US measles status to go up for review The U.S. and Mexico will meet with the Pan American Health Organization (PAHO) for a three-day closed door meeting next week to evaluate their…

Presented by AstraZeneca {beacon} Healthcare Healthcare The Big Story Following midterm losses, MAHA is at a crossroads Health Secretary Robert F.…

Presented by AstraZeneca {beacon} Healthcare Healthcare The Big Story Democrats get their health agenda ready ahead of takeover Reinstating the Affordable Care Act’s enhanced premium tax credits, reversing the Trump administration’s Medicaid cuts and even…

AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market.

The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.

From Reddit - r/neutralnews: Astrazeneca tops expectations in the first quarter on strong cancer drug sales

From Independent RSS Feed: Pharmaceutical giant to invest £300m in Britain after UK-US deal

AstraZeneca chief executive Pascal Soriot has thanked the Government ‘for their efforts to improve access for patients’

Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer

AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.